Guido Zaman and Suzanne van Gerwen will attend the EACR-AACR Special Conference, that will be held in Florence (Italy) from June 20th to 23rd.

On Monday, June 22nd, two posters will be presented: one on the application of NFK GreenScreen™ ; a second on NTRC’s TTK (Mps1) drug discovery program.

The NFK GreenScreen™ poster will show selectivity data of different IDO1 and TDO inhibitors in biochemical and cellular assays for human and mouse IDO1 and TDO.
Title: Selective inhibitors targeting indoleamine 2,3-dioxygenease and tryptophan 2,3-dioxygenase
Session: Experimental/Molecular Therapeutics, Pharmacogenesis II.
Abstract number and poster board: 527.

The TTK poster presents data of the TTK (Mps1) inhibitor program of NTRC in collaboration with the Netherlands Cancer Institute and University Medical Center Utrecht.
Title: Identification of selective inhibitors of the spindle assembly checkpoint kinase TTK (Mps1) for treatment of triple negative breast cancer
Session: Experimental/Molecular Therapeutics, Pharmacogenesis II.
Abstract number and poster board: 524.